Gemfibrozil Tablet shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-02-10 · last update 2026-02-10
Manufacturers: Pfizer Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lopid, Tablet, 600 mg (NDC 0071-0737-20) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug. | Posted 02/10/2026 Updated 02/10/2026 Discontinued 02/10/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)